Transcription factor decoy against NFATc1 in human primary osteoblasts

International Journal of Molecular Medicine

Volumn 28, Issue 2, 2011, Pages 199-206

  Penolazzi, Letizia ^a   Lisignoli, Gina ^b   Lambertini, Elisabetta ^a   Torreggiani, Elena ^a   Manferdini, Cristina ^b   Lolli, Andrea ^a   Vecchiatini, Renata ^a   Ciardo, Francesca ^a   Gabusi, Elena ^b   Facchini, Andrea ^b   Gambari, Roberto ^a   Piva, Roberta ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b RIZZOLI ORTHOPAEDIC INSTITUTE   (Italy)

Author keywords

Chromatin immunoprecipitation; Collagen type XV; Human primary osteoblasts; Nuclear factor of activated T cells; Transcription factor decoy

Indexed keywords

BIOLOGICAL MARKER; CALCIUM; COLLAGEN TYPE 15; ESTROGEN RECEPTOR ALPHA; OLIGODEOXYNUCLEOTIDE; TRANSCRIPTION FACTOR NFAT; TRANSCRIPTION FACTOR NFAT CYTOPLASMIC 1; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BIOLOGICAL ACTIVITY; BONE DISEASE; BONE MINERALIZATION; BONE TISSUE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL DIFFERENTIATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN VIVO STUDY; LEUKEMIA CELL LINE; MONITORING; OSTEOARTHRITIS; OSTEOBLAST; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DNA INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; TRABECULAR BONE; TRANSCRIPTION FACTOR DECOY; TRANSCRIPTION REGULATION;

AGED; CELL DIFFERENTIATION; CELLS, CULTURED; COLLAGEN; GENE EXPRESSION REGULATION; GENE SILENCING; HUMANS; JURKAT CELLS; MIDDLE AGED; NFATC TRANSCRIPTION FACTORS; OLIGONUCLEOTIDES; OSTEOBLASTS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; TRANSCRIPTION FACTORS; TRANSFECTION;

EID: 79958175660     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2011.701     Document Type: Article

References (41)

1. Rodan GA and Martin TJ: Therapeutic approaches to bone diseases. Science 289: 1508-1514, 2000.
2. Kwan MD, Slater BJ, Wan DC and Longaker MT: Cell-based therapies for skeletal regenerative medicine. Hum Mol Genet 17: 93-98, 2008.
3. Sitara D and Aliprantis AO: Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev 233: 286-300, 2010.
4. Fromigué O, Haÿ E, Barbara A and Marie PJ: Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. J Biol Chem 285: 25251-25258, 2010.
5. Choo MK, Yeo H and Zayzafoon M: NFATc1 mediates HDAC-dependent transcriptional repression of osteocalcin expression during osteoblast differentiation. Bone 45: 579-589, 2009.
6. Stern PH: The calcineurin-NFAT pathway and bone: intriguing new findings. Mol Interv 6: 193-196, 2006.
7. Winslow MM, Pan M, Starbuck M, Gallo EM, Deng L, Karsenty G and Crabtree GR: Calcineurin/NFAT signaling in osteoblasts regulates bone mass. Dev Cell 10: 771-782, 2006.
8. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B, Nakashima K and Takayanagi H: NFAT and Osterix cooperatively regulate bone formation. Nat Med 11: 880-885, 2005.
9. Hogan PG, Chen L, Nardone J and Rao A: Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 17: 2205-2232, 2003.
10. Wu H, Peisley A, Graef IA and Crabtree GR: NFAT signaling and the invention of vertebrates. Trends Cell Biol 17: 251-260, 2007.
11. 2+/calcineurin-NFAT-mediated signaling. Mol Cells 18: 1-9, 2004.
12. Bert AG, Johnson BV, Baxter EW and Cockerill PN: A modular enhancer is differentially regulated by GATA and NFAT elements that direct different tissue-specific patterns of nucleosome positioning and inducible chromatin remodeling. Mol Cell Biol 27: 2870-2885, 2007.
13. Macián F, López-Rodríguez C and Rao A: Partners in transcription: NFAT and AP-1. Oncogene 20: 2476-2489, 2001.
14. Yang G, Yu F, Fu H, Lu F, Huang B, Bai L, Zhao Z, Yao L and Lu Z: Identification of the distinct promoters for the two transcripts of apoptosis related protein 3 and their transcriptional regulation by NFAT and NFkappaB. Mol Cell Biochem 302: 187-194, 2007.
15. Yang XY, Wang LH, Chen T, Hodge DR, Resau JH, DaSilva L and Farrar WL: Activation of human T lymphocytes is inhibited by peroxisome proliferator-activated receptor gamma (PPARgamma) agonists. PPARgamma co-association with transcription factor NFAT. J Biol Chem 275: 4541-4544, 2000.
16. Borgatti M, Boyd DD, Lampronti I, Bianchi N, Fabbri E, Saviano M, Romanelli A, Pedone C and Gambari R: Decoy molecules based on PNA-DNA chimeras and targeting Sp1 transcription factors inhibit the activity of urokinase-type plasminogen activator receptor (uPAR) promoter. Oncol Res 15: 373-383, 2005.
17. Mann MJ and Dzau VJ: Therapeutic application of transcriptional factor decoy oligonucleotides. J Clin Invest 106: 1071-1075, 2000.
18. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J and Ogihara T: In vivo transfection of cis element 'decoy' against nuclear factor-κB binding site prevents myocardial infarction. Nat Med 3: 894-899, 1997.
19. Piva R, Penolazzi L, Lambertini E, Giordano S and Gambari R: Induction of apoptosis of human primary osteoclasts treated with a transcription factor decoy mimicking a promoter region of estrogen receptor alpha. Apoptosis 66: 1079-1094, 2005.
20. Lui VW, Boehm AL, Koppikar P, Leeman RJ, Johnson D, Ogagan M, Childs E, Freilino M and Grandis JR: Antiproliferative mechanisms of a transcription factor decoy targeting signal transducer and activator of transcription (STAT) 3: the role of STAT1. Mol Pharmacol 71: 1435-1443, 2007.
21. Bezzerri V, Borgatti M, Nicolis E, Lampronti I, Dechecchi MC, Mancini I, Rizzotti P, Gambari R and Cabrini G: Transcription factor oligodeoxynucleotides to NF-kappaB inhibit transcription of IL-8 in bronchial cells. Am J Respir Cell Mol Biol 39: 86-96, 2008.
22. Moriyama I, Ishihara S, Rumi MA, Aziz MD, Mishima Y, Oshima N, Kadota C, Kadowaki Y, Amano Y and Kinoshita Y: Decoy oligodeoxynucleotide targeting activator protein-1 (AP-1) attenuates intestinal inflammation in murine experimental colitis. Lab Invest 88: 652-663, 2008.
23. Gambari R, Borgatti M, Bezzerri V, Nicolis E, Lampronti I, Dechecchi MC, Mancini I, Tamanini A and Cabrini G: Decoy oligodeoxyribonucleotides and peptide nucleic acids-DNA chimeras targeting nuclear factor kappa-B: Inhibition of IL-8 gene expression in cystic fibrosis cells infected with Pseudomonas aeruginosa. Biochem Pharmacol 80: 1887-1894, 2010.
24. Penolazzi L, Zennaro M, Lambertini E, Tavanti E, Torreggiani E, Gambari R and Piva R: Induction of estrogen receptor alpha expression with decoy oligonucleotide targeted to NFATc1 binding sites in osteoblasts. Mol Pharmacol 71: 1457-1462, 2007.
25. Deroo BJ and Korach KS: Estrogen receptors and human disease. J Clin Invest 116: 561-570, 2006.
26. Lambertini E, Lisignoli G, Torreggiani E, Manferdini C, Gabusi E, Franceschetti T, Penolazzi L, Gambari R, Facchini A and Piva R: Slug gene expression supports human osteoblast maturation. Cell Mol Life Sci 66: 3641-3653, 2009.
27. Dignam JD, Lebovitz RM and Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11: 1475-1489, 1983.
28. Manzati E, Aguiari G, Banzi M, Manzati M, Selvatici R, Falzarano S, Maestri I, Pinton P, Rizzuto R and del Senno L: The cytoplasmic C-terminus of polycystin-1 increases cell proliferation in kidney epithelial cells through serum-activated and Ca(2+)-dependent pathway(s). Exp Cell Res 304: 391-406, 2005.
29. Tonnarelli B, Manferdini C, Piacentini A, Codeluppi K, Zini N, Ghisu S, Facchini A and Lisignoli G: Surface-dependent modulation of proliferation, bone matrix molecules, and inflammatory factors in human osteoblasts. J Biomed Mater Res 89: 687-696, 2008.
30. Lisignoli G, Codeluppi K, Todoerti K, Manferdini C, Piacentini A, Zini N, Grassi F, Cattini L, Piva R, Rizzoli V, Facchini A, Giuliani N and Neri A: Gene array profile identifies collagen type XV as a novel human osteoblast-secreted matrix protein. J Cell Physiol 220: 401-409, 2009.
31. Han W and Liu GN: EGR-1 decoy ODNs inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia of balloon-injured arteries in rat. Arterioscler Thromb Vasc Biol 29: 1080-1086, 2009.
32. Aoki T, Kataoka H, Ishibashi R, Nozaki K, Morishita R and Hashimoto N: Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukinTbeta and nuclear factor-kappaB. Life Sci 86: 234-243, 2010.
33. Stadlbauer TH, Wagner AH, Hölschermann H, Fiedel S, Fingerhuth H, Tillmanns H, Bohle RM and Hecker M: AP-1 and STAT-1 decoy oligodeoxynucleotides attenuate transplant vasculopathy in rat cardiac allografts. Cardiovasc Res 79: 698-705, 2008.
34. Semenza GL: Transcription Factors and Human Disease. Oxford Monographs on Medical Genetics. 1st edition. Oxford University Press, New York, 1998.
35. Blancafort P, Segal DJ and Barbas CF III: Designing transcription factor architectures for drug discovery. Mol Pharmacol 66: 1361-1371, 2004.
36. Takayanagi H: The role of NFAT in osteoclast formation. Ann NY Acad Sci 1116: 227-237, 2007.
37. Zayzafoon M: Inhibition of NFAT increases osteoblast differentiation by increasing Fra-2 expression. J Musculoskelet Neuronal Interact 5: 347, 2005.
38. Kim JH, Kim K, Youn BU, Jin HM and Kim N: MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR. Cell Signal 22: 1341-1349, 2010.
39. Zallone A: Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann NY Acad Sci 1068: 173-179, 2006.
40. Eklund L, Muona A, Liétard J and Pihlajaniemi T: Structure of the mouse type XV collagen gene, Col15a1, comparison with the human COL15A1 gene and functional analysis of the promoters of both genes. Matrix Biol 19: 489-500, 2000.
41. Bozec A, Bakiri L, Jimenez M, Schinke T, Amling M and Wagner EF: Fra-2/AP-1 controls bone formation by regulating osteoblast differentiation and collagen production. J Cell Biol 190: 1093-1106, 2010.